“…Our data, together with two DCM population screenings (49, 50), the study of other cardiomyopathies (HCM and restrictive) (13, 14), and previous data on MFM (4, 10, 12, 33, 34), suggest that FLNC rare variants can cause a spectrum of cardiac and skeletal muscle phenotypes. Finally, studies in vivo (mice, zebrafish and medaka fish) (24, 47, 51) further support our findings that suggest FLNC mutations can lead to sarcomeric structural changes and ultimately cause cardiac dysfunction.…”